We assessed proteopathic tau seeding and propagation in tau-FRET assays and in vivo stereotaxic seeding and propagation experiments using AD brain–derived insoluble tau aggregates (Figures 3 and 6). The gene discussed is MAPT; the disease is Alzheimer disease.